229 related articles for article (PubMed ID: 30671048)
1. Troglitazone Impedes the Oligomerization of Sodium Taurocholate Cotransporting Polypeptide and Entry of Hepatitis B Virus Into Hepatocytes.
Fukano K; Tsukuda S; Oshima M; Suzuki R; Aizaki H; Ohki M; Park SY; Muramatsu M; Wakita T; Sureau C; Ogasawara Y; Watashi K
Front Microbiol; 2018; 9():3257. PubMed ID: 30671048
[TBL] [Abstract][Full Text] [Related]
2. NTCP Oligomerization Occurs Downstream of the NTCP-EGFR Interaction during Hepatitis B Virus Internalization.
Fukano K; Oshima M; Tsukuda S; Aizaki H; Ohki M; Park SY; Wakita T; Wakae K; Watashi K; Muramatsu M
J Virol; 2021 Nov; 95(24):e0093821. PubMed ID: 34613794
[TBL] [Abstract][Full Text] [Related]
3. A Novel Tricyclic Polyketide, Vanitaracin A, Specifically Inhibits the Entry of Hepatitis B and D Viruses by Targeting Sodium Taurocholate Cotransporting Polypeptide.
Kaneko M; Watashi K; Kamisuki S; Matsunaga H; Iwamoto M; Kawai F; Ohashi H; Tsukuda S; Shimura S; Suzuki R; Aizaki H; Sugiyama M; Park SY; Ito T; Ohtani N; Sugawara F; Tanaka Y; Mizokami M; Sureau C; Wakita T
J Virol; 2015 Dec; 89(23):11945-53. PubMed ID: 26378168
[TBL] [Abstract][Full Text] [Related]
4. Chemical array system, a platform to identify novel hepatitis B virus entry inhibitors targeting sodium taurocholate cotransporting polypeptide.
Kaneko M; Futamura Y; Tsukuda S; Kondoh Y; Sekine T; Hirano H; Fukano K; Ohashi H; Saso W; Morishita R; Matsunaga S; Kawai F; Ryo A; Park SY; Suzuki R; Aizaki H; Ohtani N; Sureau C; Wakita T; Osada H; Watashi K
Sci Rep; 2018 Feb; 8(1):2769. PubMed ID: 29426822
[TBL] [Abstract][Full Text] [Related]
5. Kinetics of the bile acid transporter and hepatitis B virus receptor Na+/taurocholate cotransporting polypeptide (NTCP) in hepatocytes.
König A; Döring B; Mohr C; Geipel A; Geyer J; Glebe D
J Hepatol; 2014 Oct; 61(4):867-75. PubMed ID: 24845614
[TBL] [Abstract][Full Text] [Related]
6. Cyclosporin A and its analogs inhibit hepatitis B virus entry into cultured hepatocytes through targeting a membrane transporter, sodium taurocholate cotransporting polypeptide (NTCP).
Watashi K; Sluder A; Daito T; Matsunaga S; Ryo A; Nagamori S; Iwamoto M; Nakajima S; Tsukuda S; Borroto-Esoda K; Sugiyama M; Tanaka Y; Kanai Y; Kusuhara H; Mizokami M; Wakita T
Hepatology; 2014 May; 59(5):1726-37. PubMed ID: 24375637
[TBL] [Abstract][Full Text] [Related]
7. A new strategy to identify hepatitis B virus entry inhibitors by AlphaScreen technology targeting the envelope-receptor interaction.
Saso W; Tsukuda S; Ohashi H; Fukano K; Morishita R; Matsunaga S; Ohki M; Ryo A; Park SY; Suzuki R; Aizaki H; Muramatsu M; Sureau C; Wakita T; Matano T; Watashi K
Biochem Biophys Res Commun; 2018 Jun; 501(2):374-379. PubMed ID: 29730285
[TBL] [Abstract][Full Text] [Related]
8. Tyrosine 146 of the Human Na
Zakrzewicz D; Leidolf R; Kunz S; Müller SF; Neubauer A; Leiting S; Goldmann N; Lehmann F; Glebe D; Geyer J
Viruses; 2022 Jun; 14(6):. PubMed ID: 35746730
[TBL] [Abstract][Full Text] [Related]
9. Unusual Features of Sodium Taurocholate Cotransporting Polypeptide as a Hepatitis B Virus Receptor.
Li J; Zong L; Sureau C; Barker L; Wands JR; Tong S
J Virol; 2016 Sep; 90(18):8302-13. PubMed ID: 27384660
[TBL] [Abstract][Full Text] [Related]
10. The machinery for endocytosis of epidermal growth factor receptor coordinates the transport of incoming hepatitis B virus to the endosomal network.
Iwamoto M; Saso W; Nishioka K; Ohashi H; Sugiyama R; Ryo A; Ohki M; Yun JH; Park SY; Ohshima T; Suzuki R; Aizaki H; Muramatsu M; Matano T; Iwami S; Sureau C; Wakita T; Watashi K
J Biol Chem; 2020 Jan; 295(3):800-807. PubMed ID: 31836663
[TBL] [Abstract][Full Text] [Related]
11. Amentoflavone inhibits hepatitis B virus infection via the suppression of preS1 binding to host cells.
Aoki-Utsubo C; Indrasetiawan P; Fukano K; Muramatsu M; Artanti N; Hanafi M; Hotta H; Kameoka M
Microbiol Immunol; 2023 Jun; 67(6):281-292. PubMed ID: 36929353
[TBL] [Abstract][Full Text] [Related]
12. Epidermal growth factor receptor is a host-entry cofactor triggering hepatitis B virus internalization.
Iwamoto M; Saso W; Sugiyama R; Ishii K; Ohki M; Nagamori S; Suzuki R; Aizaki H; Ryo A; Yun JH; Park SY; Ohtani N; Muramatsu M; Iwami S; Tanaka Y; Sureau C; Wakita T; Watashi K
Proc Natl Acad Sci U S A; 2019 Apr; 116(17):8487-8492. PubMed ID: 30952782
[TBL] [Abstract][Full Text] [Related]
13. A new class of hepatitis B and D virus entry inhibitors, proanthocyanidin and its analogs, that directly act on the viral large surface proteins.
Tsukuda S; Watashi K; Hojima T; Isogawa M; Iwamoto M; Omagari K; Suzuki R; Aizaki H; Kojima S; Sugiyama M; Saito A; Tanaka Y; Mizokami M; Sureau C; Wakita T
Hepatology; 2017 Apr; 65(4):1104-1116. PubMed ID: 27863453
[TBL] [Abstract][Full Text] [Related]
14. Cyclosporin A inhibits hepatitis B and hepatitis D virus entry by cyclophilin-independent interference with the NTCP receptor.
Nkongolo S; Ni Y; Lempp FA; Kaufman C; Lindner T; Esser-Nobis K; Lohmann V; Mier W; Mehrle S; Urban S
J Hepatol; 2014 Apr; 60(4):723-31. PubMed ID: 24295872
[TBL] [Abstract][Full Text] [Related]
15. Strategies to inhibit entry of HBV and HDV into hepatocytes.
Urban S; Bartenschlager R; Kubitz R; Zoulim F
Gastroenterology; 2014 Jul; 147(1):48-64. PubMed ID: 24768844
[TBL] [Abstract][Full Text] [Related]
16. Inhibitors of hepatitis B virus attachment and entry.
Lempp FA; Urban S
Intervirology; 2014; 57(3-4):151-7. PubMed ID: 25034482
[TBL] [Abstract][Full Text] [Related]
17. Evaluation and identification of hepatitis B virus entry inhibitors using HepG2 cells overexpressing a membrane transporter NTCP.
Iwamoto M; Watashi K; Tsukuda S; Aly HH; Fukasawa M; Fujimoto A; Suzuki R; Aizaki H; Ito T; Koiwai O; Kusuhara H; Wakita T
Biochem Biophys Res Commun; 2014 Jan; 443(3):808-13. PubMed ID: 24342612
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B and D viruses exploit sodium taurocholate co-transporting polypeptide for species-specific entry into hepatocytes.
Ni Y; Lempp FA; Mehrle S; Nkongolo S; Kaufman C; Fälth M; Stindt J; Königer C; Nassal M; Kubitz R; Sültmann H; Urban S
Gastroenterology; 2014 Apr; 146(4):1070-83. PubMed ID: 24361467
[TBL] [Abstract][Full Text] [Related]
19. Sodium taurocholate cotransporting polypeptide inhibition efficiently blocks hepatitis B virus spread in mice with a humanized liver.
Nakabori T; Hikita H; Murai K; Nozaki Y; Kai Y; Makino Y; Saito Y; Tanaka S; Wada H; Eguchi H; Takahashi T; Suemizu H; Sakamori R; Hiramatsu N; Tatsumi T; Takehara T
Sci Rep; 2016 Jun; 6():27782. PubMed ID: 27278060
[TBL] [Abstract][Full Text] [Related]
20. The p.Ser267Phe variant of sodium taurocholate cotransporting polypeptide (NTCP) supports HBV infection with a low efficiency.
Liu C; Xu G; Gao Z; Zhou Z; Guo G; Li D; Jing Z; Sui J; Li W
Virology; 2018 Sep; 522():168-176. PubMed ID: 30032030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
